CMS Issues First Request For Public Comments On The Medicare Drug Price Negotiation Program
The Inflation Reduction Act's ("IRA") drug price negotiation provisions have captured the pharmaceutical and biotech industry's attention. In part, the IRA allows the Centers for Medicare & Medicaid
Source: mondaq.com